Tactile Systems Technology Inc(TCMD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 20.63 | EPS (ttm) | 1.09 | Insider Own | 4.29% | Shs Outstand | 22.7M | Perf Week | 1.77% |
| Market Cap | 0.51B | Forward P/E | 14.61 | EPS next Y | 37.31% | Insider Trans | -1.58% | Shs Float | 21.7M | Perf Month | -8.61% |
| Enterprise Value | 0.45B | PEG | 0.39 | EPS next Q | 0.28 | Inst Own | 103.12% | Short Float | 12.04% | Perf Quarter | -14.99% |
| Income | 0.02B | P/S | 1.45 | EPS this Y | 36.18% | Inst Trans | -2.96% | Short Ratio | 8.85 | Perf Half Y | -18.75% |
| Sales | 0.35B | P/B | 2.27 | EPS next 5Y | 37.89% | ROA | 9% | Short Interest | 2.61M | Perf YTD | -22.76% |
| Book/sh | 9.86 | P/C | 7.26 | EPS past 3/5Y | - | ROE | 11.88% | 52W High | -40.69% ($37.77) | Perf Year | 63.38% |
| Cash/sh | 3.08 | P/FCF | 18.92 | Sales past 3/5Y | 10.12% 11.98% | ROIC | 10.58% | 52W Low | 69.57% ($13.21) | Perf 3Y | 23.35% |
| Dividend Est. | - | EV/EBITDA | 10.83 | EPS Y/Y TTM | 74.89% | Gross Margin | 76.08% | Volatility(W/M) | 3.58% 3.85% | Perf 5Y | -47.23% |
| Dividend TTM | - | EV/Sales | 1.29 | Sales Y/Y TTM | 17.22% | Oper. Margin | 10% | ATR (14) | 0.95 | Perf 10Y | 40.44% |
| Dividend Ex-Date | - | Quick Ratio | 3.68 | EPS Q/Q | 143.93% | Profit Margin | 7.1% | RSI (14) | 36.14 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.12 | Sales Q/Q | 8.61% | SMA20 | -2.65% ($23.01) | Beta | 0.82 | Target Price | $39 |
| Payout | - | Debt/Eq | 0.06 | Earnings | 2026/8/10 | SMA50 | -14.97% ($26.34) | Rel Volume | 0.82 | Prev Close | $22.32 |
| Employees | 1086 | LT Debt/Eq | 0.05 | EPS/Sales Surpr. | 151.85% 0.21% | SMA200 | -16.63% ($26.87) | Avg Volume(3M) | 0.29M | Price | $22.4 |
| IPO | 2016/7/28 | Option/Short | Yes/Yes | Trades | 3661 | Volume | 240,336 | Change | 0.36% |
Company
TCMD is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🩺 Tactile Systems Technology (TCMD) is a U.S. medical device company that develops and sells home-use medical equipment for patients with chronic conditions. Its flagship products include pneumatic compression devices for lymphedema treatment (Flexitouch, Entre, and Nimbl) and airway clearance vests for respiratory illnesses (AffloVest), and the company is characterized by a high gross profit margin driven by its direct sales model.
Over the past 1 year, roughly in the middle
41% below its 1-year high.
TCMD makes money exceptionally well
10% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +36.2% this year.
Tap to view numbers
The price looks about right
Trading at 20.6 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +23.4% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 103.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
HULL 0.01%
XHE 0.01%
FDLS 0.01%
VAMO 0.01%
MYLD 0.01%It ranks #4 in the industry
Based on market cap of $507M.
TCMD $507M PER 20.6
ABT $176B PER 33.0
MDT $116B PER 22.4
SYK $106B PER 28.6
FAQ
What kind of company is TCMD?
TCMD belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of TCMD?
The market cap of TCMD is approximately $507M, ranking 3,211 within its sector.
What is the P/E ratio of TCMD?
TCMD has a P/E ratio of approximately 20.6x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for TCMD?
TCMD has recorded a 52-week high of $37.77 and a low of $13.21.
